Found Down Extremity Compartment Syndrome Secondary to Substance Use: An Observational Multicenter Study.

Smith RDJ, Mortensen SJ, Zhang D, Smith MR, Weaver MJ, von Keudell AG

How quality of life can help guide selection of androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer.

Smith MR

Plasma Metabolic Phenotypes of HPV-Associated versus Smoking-Associated Head and Neck Cancer and Patient Survival.

Eldridge RC, Uppal K, Hayes DN, Smith MR, Hu X, Qin ZS, Beitler JJ, Miller AH, Wommack EC, Higgins KA, Shin DM, Ulrich B, Qian DC, Saba NF, Bruner DW, Jones DP, Xiao C

Swallow-induced syncope after magnetic sphincter augmentation: a case report and physiologic explanation.

Smith MR, Ayazi S, Grubic AD, Shen X, Jobe BA

A scalable workflow to characterize the human exposome.

Hu X, Walker DI, Liang Y, Smith MR, Orr ML, Juran BD, Ma C, Uppal K, Koval M, Martin GS, Neujahr DC, Marsit CJ, Go YM, Pennell KD, Miller GW, Lazaridis KN, Jones DP

Genomic signatures of Lake Erie bacteria suggest interaction in the Microcystis phycosphere.

Hoke AK, Reynoso G, Smith MR, Gardner MI, Lockwood DJ, Gilbert NE, Wilhelm SW, Becker IR, Brennan GJ, Crider KE, Farnan SR, Mendoza V, Poole AC, Zimmerman ZP, Utz LK, Wurch LL, Steffen MM

Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.

Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Mohamed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Fizazi K

Myological variation in the forearm anatomy of Callitrichidae and Lemuridae.

Dickinson E, Boettcher ML, Smith MR, Worden NA, Swindell SR, Seelye JS, Pastor F, Hartstone-Rose A

Crystal-storing histiocytes in ascites leading to a diagnosis of plasma cell myeloma.

Hamadeh F, Smith MR, Hsi ED

Blood Biomarker Landscape in Patients with High-risk Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide and Androgen-Deprivation Therapy as They Progress to Metastatic Disease.

Smith MR, Thomas S, Gormley M, Chowdhury S, Olmos D, Oudard S, Feng FY, Rajpurohit Y, Urtishak K, Ricci DS, Rooney B, Lopez-Gitlitz A, Yu M, Wyatt AW, Li M, Attard G, Small EJ